Inhibition of Bcl-2 signaling at nanomolar concentrations by small molecule BH3 inhibitor, ABT-737 as a novel therapeutic strategy in acute myeloid leukemia (AML).

被引：1

作者：

Contractor, R

Konopleva, M

Deng, XM

Harris, D

Ruvolo, P

Estrov, Z

May, WS

Rosenberg, SH

Andreeff, M

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX USA

[2] Univ Florida, Shands Canc Ctr, Gainesville, FL USA

[3] Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX USA

[4] Abbott Labs, Abbott Pk, IL 60064 USA

来源：

关键词：

D O I：

10.1182/blood.V104.11.760.760

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

760

引用

页码：217A / 218A

页数：2